Ticker brief
TXG 10X GENOMICS INC-CLASS A
Consumer, Non-cyclical · Healthcare-Products
last close
$39.01
1 day
-0.1%
14 days
+12.2%
mkt cap
$5.0B
signals 14d
15
authors 14d
12
Sentiment — last 14 days
daily mean sentiment, 2026-06-20 → 2026-07-01 · now +0.11 (−1 bearish … +1 bullish)
Who spoke12
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @davevermilion | A | -2.03 | 2 | -0.12 |
| @LogicalThesis | A | -0.02 | 2 | +0.05 |
| @SteveDJacobs | C | -0.20 | 2 | +0.20 |
| @ThePupOfWallSt | C | -2.68 | 1 | +0.10 |
| @MikeJTrades | C | · | 1 | +0.00 |
| @NickDrendel | C | +0.19 | 1 | +0.35 |
| @KeithMcCullough | A | +0.52 | 1 | +0.45 |
| @RealSimpleAriel | C | -0.70 | 1 | +0.55 |
| @OracleNYSE | C | +0.49 | 1 | +0.10 |
| @EmmanuelInvest | C | -1.12 | 1 | +0.35 |
| @WallStDiaries | C | +0.45 | 1 | +0.25 |
| @fundmyfund | B | -2.01 | 1 | +0.25 |
Recent signals15of 15 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-07-01 | @davevermilion | -0.40 | Recaps VITL up almost 50% in 2 months and other positions sarcastically. | -0.1% | tweet ↗ |
| 2026-07-01 | @fundmyfund | +0.25 | States TXG is a top-3 position in ARK Genomics ETF. | -0.1% | tweet ↗ |
| 2026-07-01 | @WallStDiaries | +0.25 | Merck KGaA agrees to buy Bio-Techne for $11.3B, boosting life sciences sentiment. | -0.1% | tweet ↗ |
| 2026-07-01 | @EmmanuelInvest | +0.35 | Piper Sandler raises TXG PT to $42 from $20. | -0.1% | tweet ↗ |
| 2026-06-30 | @OracleNYSE | +0.10 | FT says Anthropic launches Claude Science in push for pharma revenue. | +1.7% | tweet ↗ |
| 2026-06-28 | @SteveDJacobs | +0.20 | Screener lists 13 stocks passing both Qullamaggie and Minervini inspired screens. | +6.1% | tweet ↗ |
| 2026-06-27 | @SteveDJacobs | +0.20 | Qullamaggie-inspired screener lists 58 stocks, including 39 non-extended names. | +6.1% | tweet ↗ |
| 2026-06-26 | @LogicalThesis | +0.10 | Author says TXG can go higher but multi-bagger returns are tougher after a 50% move. | +6.1% | tweet ↗ |
| 2026-06-26 | @LogicalThesis | +0.00 | Author says he fumbled TXG around 16 due to volatility, describing a past trade mistake. | +6.1% | tweet ↗ |
| 2026-06-25 | @RealSimpleAriel | +0.55 | Daily recap emphasizes biotech/genomics and builders leading while mega-cap tech lags. | +9.2% | tweet ↗ |
| 2026-06-24 | @KeithMcCullough | +0.45 | Calls TXG a Signal Strength Stock. | +12.7% | tweet ↗ |
| 2026-06-24 | @davevermilion | +0.15 | Mentions owned names and watching TEM with mild constructive view. | +12.7% | tweet ↗ |
| 2026-06-24 | @NickDrendel | +0.35 | Genomics theme at new highs and lists leaders. | +12.7% | tweet ↗ |
| 2026-06-20 | @MikeJTrades | +0.00 | Notes broadening wedge and price range. | +12.2% | tweet ↗ |
| 2026-06-20 | @ThePupOfWallSt | +0.10 | ARKG base breakout with upside roadmap and call premium suggests bullish bets. | +12.2% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.